SBC Medical Group Holdings (SBC) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
9 Jul, 2026Opening remarks and agenda
Meeting commenced at 9:00 A.M. JST in a virtual format to increase inclusivity and reach more stockholders.
CEO Yoshiyuki Aikawa chaired the meeting, joined by directors and legal counsel.
Housekeeping items and meeting conduct rules were outlined, including recording and forward-looking statement disclaimers.
Board and executive committee updates
Directors present included Yoshiyuki Aikawa, Yuya Yoshida, Ken Edahiro, Mike Sayama, and Fumitoshi Fujiwara.
MaloneBailey, LLP representatives attended as independent auditors.
Shareholder proposals
Seven proposals were presented: election of directors, ratification of auditors, and five charter amendments (eliminating plurality voting, removing 'for cause' director removal, opting out of Section 203, officer exculpation, and technical amendments).
Board recommended voting in favor of all proposals and nominees.
Latest events from SBC Medical Group Holdings
- AI-driven growth, global expansion, and multi-brand strategies fuel accelerating performance.SBC
Small-Cap Virtual Conference - Profit and revenue surged as AI, new formats, and global expansion fueled renewed growth.SBC
Q3 Investor Summit Group Virtual Conference 2026 - Q2 2026 saw accelerated growth, AI-driven efficiency, and expansion in healthcare and global markets.SBC
Emerging Growth Conference - Leading Japanese aesthetic clinic group achieves rapid global growth and strong financial results.SBC
Corporate presentation - Q2 2026 net income surged 335% on 13% revenue growth, fueled by AI and network expansion.SBC
Q2 2026 - Underlying growth, AI-driven efficiency, and longevity-focused expansion drive future prospects.SBC
Sidoti Small-Cap Virtual Investor Conference - AI-driven, multi-brand healthcare model targets global expansion and double-digit growth.SBC
Emerging Growth Conference 93 - Largest aesthetic clinic network in Japan, expanding globally with high growth and profitability.SBC
Investor presentation - Strong financials, global expansion, and strategic initiatives drive growth and shareholder value.SBC
Life Sciences Investor Forum